Overview

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of therapeutic anticoagulation with tinzaparin during pregnancy via weight-based dosing.
Phase:
Phase 4
Details
Lead Sponsor:
University of Calgary
Collaborator:
LEO Pharma
Treatments:
Dalteparin
Heparin, Low-Molecular-Weight
Tinzaparin